Get the Stockscreener App
1.40
1.41%
-0.02
Pmv Pharmaceuticals Inc stock is traded at $1.40, with a volume of 154.73K.
It is down -1.41% in the last 24 hours and up +33.33% over the past month.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. Its pipeline rezatapopt PYNNACLE, rezatapopt and azacitidine, rezatapopt (PC14586), and PMV-586-101.
See More
Previous Close:
$1.42
Open:
$1.4
24h Volume:
154.73K
Relative Volume:
0.55
Market Cap:
$72.73M
Revenue:
-
Net Income/Loss:
$-51.47M
P/E Ratio:
-1.40
EPS:
-1
Net Cash Flow:
$-47.50M
1W Performance:
-0.71%
1M Performance:
+33.33%
6M Performance:
-1.41%
1Y Performance:
-11.95%
1-Day Range:
$1.35
$1.41
1-Week Range:
$1.35
$1.55
52-Week Range:
$0.81
$1.82
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Name
Pmv Pharmaceuticals Inc
Sector
Industry
Phone
(609) 642-6670
Address
400 ALEXANDER PARK DRIVE, PRINCETON
Compare PMVP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PMVP
Pmv Pharmaceuticals Inc
|
1.40 | 73.77M | 0 | -51.47M | -47.50M | -1.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-08-24 | Upgrade | Oppenheimer | Perform → Outperform |
| May-13-24 | Initiated | Craig Hallum | Buy |
| Apr-12-24 | Initiated | Jefferies | Buy |
| Dec-27-23 | Initiated | Ladenburg Thalmann | Buy |
| Mar-02-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-22-21 | Upgrade | Goldman | Neutral → Buy |
| Aug-19-21 | Initiated | Oppenheimer | Perform |
| Aug-02-21 | Initiated | Guggenheim | Buy |
| Jul-29-21 | Initiated | H.C. Wainwright | Buy |
| Oct-20-20 | Initiated | BofA Securities | Buy |
| Oct-20-20 | Initiated | Cowen | Outperform |
| Oct-20-20 | Initiated | Evercore ISI | Outperform |
| Oct-20-20 | Initiated | Goldman | Neutral |
View All
Pmv Pharmaceuticals Inc Stock (PMVP) Latest News
Will PMV Pharmaceuticals Inc. rebound enough to break evenFree Daily Picks With Predictable Performance - Newser
Visual analytics tools that track PMV Pharmaceuticals Inc. performanceWeekly Price Target Forecast and Alerts - Newser
How does PMV Pharmaceuticals Inc. compare to its industry peersPost Market Opportunities With High Returns - jammulinksnews.com
Is PMV Pharmaceuticals Inc. a candidate for recovery playBuy Point Strategy with Profit Protection - Newser
Is a relief rally coming for PMV Pharmaceuticals Inc. holdersAI Powered Stock Market Trend Forecast - Newser
How to interpret RSI for PMV Pharmaceuticals Inc. stockEarnings Based Stock Performance Forecast - Newser
What MACD and RSI say about PMV Pharmaceuticals Inc.Deep Stock Performance and Volatility Analysis - Newser
How high can PMV Pharmaceuticals Inc. stock goHigh Accuracy Trade Setup Identification - Newser
How to integrate PMV Pharmaceuticals Inc. into portfolio analysis toolsDay Trading Setup and Momentum Analysis - Newser
Should you wait for a breakout in PMV Pharmaceuticals Inc.Free Trade Setups With Clear Risk Limits - Newser
Why PMV Pharmaceuticals Inc. stock attracts strong analyst attentionWeekly Chart Watchlist with Trade Guidance - Newser
Heatmap analysis for PMV Pharmaceuticals Inc. and competitorsReal-Time Entry Signals for Top Stocks - Newser
Published on: 2025-07-30 23:35:44 - metal.it
Risk vs reward if holding onto PMV Pharmaceuticals Inc.Price Action Summary and Entry Strategy Guide - Newser
PMV Pharmaceuticals Inc. Stock Performance After Earnings: Historical InsightsFree Sector Based Breakout Stock Forecast - Newser
Is PMV Pharmaceuticals Inc. forming a reversal patternForecast Model for Intraday Buy Signals - Newser
What to do if you’re stuck in PMV Pharmaceuticals Inc.Weekly Market Direction and Sector Summary - Newser
Published on: 2025-07-30 00:45:41 - Newser
PMV Pharmaceuticals Inc (PMVP Stock: A Sea of Opportunity - investchronicle.com
What does PMVP's flat EPS in 2024 indicate for investors? - AInvest
What makes MetaVia Inc. stock price move sharplyWeekly Outlook for Short Term Investors - Newser
PMV Pharmaceuticals Inc. Recovers — But Is It SustainableReal-Time Analysis With Entry Targets In Progress - metal.it
How strong is PMV Pharmaceuticals Inc. company’s balance sheetOutperformance with explosive growth - jammulinksnews.com
Is PMV Pharmaceuticals Inc. a growth stock or a value stockGame-changing returns - jammulinksnews.com
What makes EOSE stock price move sharplyTechnical Confirmation System with Signal Alerts - Newser
Will MTUL stock recover after recent dropInvestment Life Cycle Planning Summary - Newser
Using data models to predict Angi Inc. stock movementValue Investing Checklist with Entry Signals - Newser
When is PMV Pharmaceuticals Inc. stock expected to show significant growthFree Daily Trading Room Entry - jammulinksnews.com
Why PMV Pharmaceuticals Inc. stock attracts strong analyst attention Watchlist Generator for Smart Money Signals - metal.it
What is IPDN company’s growth strategyTriple-digit returns - jammulinksnews.com
Should I hold or sell PMV Pharmaceuticals Inc. stock in 2025Consistently outstanding ROI - jammulinksnews.com
New Product Launches: Will They Boost PMV Pharmaceuticals Inc. Stock in 2025Defensive Stock Picks with Upside - metal.it
What are FURY company’s key revenue driversStrong return on assets - jammulinksnews.com
What are PMV Pharmaceuticals Inc. company’s key revenue driversUncover the best stocks for explosive growth - jammulinksnews.com
What analysts say about PMV Pharmaceuticals Inc. stock outlookAI Powered Stock Call - Newser
Smith Midland Corporation Stock Support and Resistance Levels You Should KnowInvestor Favorite Picks - Newser
Buy Signal for The Hanover Insurance Group Inc. Stock Key Technical Indicators to WatchConsistent Growth Alert - Newser
How Efficient Is MATW at Controlling Operating CostsProven Win Setups - Newser
How Tennant Company stock performs during market volatilityFree Market Dynamics Reports - Newser
What analysts say about PMV Pharmaceuticals Inc. stockSkyrocketing returns - PrintWeekIndia
Pmv Pharmaceuticals Inc Stock (PMVP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pmv Pharmaceuticals Inc Stock (PMVP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Jalota Deepika | Chief Development Officer |
Jul 01 '25 |
Sale |
1.06 |
33,065 |
35,198 |
89,959 |
| Carulli Michael | Chief Financial Officer |
Jul 01 '25 |
Sale |
1.06 |
28,249 |
30,077 |
60,146 |
| Mack David Henry | President and CEO |
Jul 01 '25 |
Sale |
1.06 |
58,411 |
62,179 |
536,133 |
| Mack David Henry | President and CEO |
Dec 03 '24 |
Option Exercise |
0.53 |
91,750 |
48,628 |
534,210 |
| Mack David Henry | President and CEO |
Jan 03 '25 |
Option Exercise |
0.53 |
17,709 |
9,386 |
551,919 |
| Jalota Deepika | Chief Development Officer |
Sep 11 '24 |
Sale |
1.50 |
7,218 |
10,853 |
118,283 |
| Carulli Michael | Chief Financial Officer |
Sep 11 '24 |
Sale |
1.50 |
2,891 |
4,347 |
88,395 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):